Pharmafile Logo

News and Press Releases

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

11 September 2024 -- Cambridge, UK -- MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test...

Category: Biotechnology, Other
Posted: September 11, 2024

MicrosensDx
info@microsensdx.com
204 Cambridge Science Park, Milton Road, Cambridge, CB4 0GZ

Nuclera Awarded £1.14m Innovate UK Funding for Development of eProtein Discovery

£790,000 FASST grant, in collaboration with DeepMirror, and £350,000 Engineering Biology grant awarded for platform development 6 June 2024 -- Cambridge, UK -- Nuclera, the biotechnology company accelerating protein expression...

Category: BioManufacturing, Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 6, 2024

Nuclera
hello@nuclera.com
One Vision Park, Station Road, Impington, Cambridge, CB24 9NP

Nuclera eProtein Discovery system installed at leading academic institutes

11 installs successfully completed Novel platform automates and accelerates protein production, enabling scale-up to mg amount in less than 48 hours List of institutes includes, University College London, University of...

Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 2, 2024

Nuclera
hello@nuclera.com
One Vision Park, Station Road, Impington, Cambridge, CB24 9NP

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

Sponsored PhD student will join Professor Ed Tate’s group at Imperial College London, UK, in the EPSRC Centre for Doctoral Training in Chemical Biology Project aims to develop the next...

Category: Biotechnology, Drug Discovery
Posted: October 4, 2023

Ubiquigent
services@ubiquigent.com
University Incubator Dundee Technopole James Lindsay Place Dundee DD1 5JJ Scotland, UK